One of the things that cancer threatens to take from the people who have been diagnosed with it and their loved ones is hope. When a patient has a cancer prognosis that is particularly grim it can be difficult for the patient and their family to hold on to the hope of their loved one living a healthy life or to embrace the idea that the disease is beatable. While doctors have managed to eradicate a wide number of diseases that once regularly threatened the lives of many people without a foreseeable end in sight cancer continues to present a formidable challenge to oncologists. While the certainty of a long life is not necessarily guaranteed to anyone one East Coast cancer research center is working hard to ensure that cancer becomes one less factor that threatens people’s lives. In addition to this The NY Times wrote in an article that it is helping to pioneer advancements in a new field of medicine while doing so.
The Rutgers Cancer Institute of New Jersey is home to scientists who cross the divides between academia and clinical practice by applying the discoveries yielded by their research to their work as physicians. In a report by Yahoo, the Institute’s researchers have produced and continue to produce groundbreaking work in the new field of precision medicine. Through the marriage of genomic science and precision medicine the Rutgers Cancer Institute has made history by being among the vanguard of cancer research organizations in the United States that use genomic sequencing as a tool to better understand cancer. What makes the Institue stand out is its use of precision medicine to guide the way cancer patients are treated.
When the team at Rutgers Cancer Institute married genomic sequencing and precision medicine it enabled them to see opportunities for patients with cancers that can be particularly difficult to treat, that is patients with cancers that do not tend to occur often and cancers with outlooks where the likelihood of survival is not high. By operating at this particular intersection of science and medicine the researchers were able to better understand these challenging forms of cancer. In 2015 this important research got a boost from a New Jersey man named Omar Boraie. The website Newswise published a report noting that Boraie and his family decided to donate $1.5 million to the work of the Rutgers Cancer Institute. The money went toward creating an endowed chair known as the Omar Boraie Chair in Genomic Science. Dr. Shridar Ganesan, a leading oncology expert, was named to the position which will enable him to advance the innovative work that the Rutgers Cancer Institute is doing.